These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7119301)
41. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Weiner P; Weiner M; Azgad Y Thorax; 1995 Dec; 50(12):1270-3. PubMed ID: 8553300 [TBL] [Abstract][Full Text] [Related]
42. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. Bisgaard H; Damkjaer Nielsen M; Andersen B; Andersen P; Foged N; Fuglsang G; Høst A; Leth C; Pedersen M; Pelck I J Allergy Clin Immunol; 1988 Jun; 81(6):1088-95. PubMed ID: 3288682 [TBL] [Abstract][Full Text] [Related]
43. Dose-response of inhaled drugs in asthma. An update. Clark DJ; Lipworth BJ Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556 [TBL] [Abstract][Full Text] [Related]
44. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Ninan TK; Reid IW; Carter PE; Smail PJ; Russell G Thorax; 1993 Jun; 48(6):599-602. PubMed ID: 8346487 [TBL] [Abstract][Full Text] [Related]
45. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma. Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023). Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Nicolaidou P J Pediatr Endocrinol Metab; 2007 Feb; 20(2):261; author reply 261-2. PubMed ID: 17396445 [No Abstract] [Full Text] [Related]
47. High dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. A two-year study. Adelroth E; Rosenhall L; Glennow C Allergy; 1985 Jan; 40(1):58-64. PubMed ID: 3977028 [TBL] [Abstract][Full Text] [Related]
48. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. Agertoft L; Pedersen S J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245 [TBL] [Abstract][Full Text] [Related]
49. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Clark DJ; Grove A; Cargill RI; Lipworth BJ Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128 [TBL] [Abstract][Full Text] [Related]
50. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918 [TBL] [Abstract][Full Text] [Related]
51. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients. Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712 [TBL] [Abstract][Full Text] [Related]
53. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations. Brannan MD; Herron JM; Reidenberg P; Affrime MB Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565 [TBL] [Abstract][Full Text] [Related]
54. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma. Phillips K; Oborne J; Harrison TW; Tattersfield AE Thorax; 2004 Jan; 59(1):21-5. PubMed ID: 14694241 [TBL] [Abstract][Full Text] [Related]
56. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Brown PH; Blundell G; Greening AP; Crompton GK Respir Med; 1991 Nov; 85(6):511-6. PubMed ID: 1775678 [TBL] [Abstract][Full Text] [Related]
57. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. Dolan LM; Kesarwala HH; Holroyde JC; Fischer TJ J Allergy Clin Immunol; 1987 Jul; 80(1):81-7. PubMed ID: 3598031 [TBL] [Abstract][Full Text] [Related]
58. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma. Sears MR; Taylor DR; Print CG; Lake DC; Herbison GP; Flannery EM Chest; 1992 Dec; 102(6):1709-15. PubMed ID: 1446477 [TBL] [Abstract][Full Text] [Related]
59. The efficacy of high dose inhaled budesonide in replacing oral corticosteroid in Asian patients with chronic asthma. Tan WC; Chan TB; Lim TK; Wong EC Singapore Med J; 1990 Apr; 31(2):142-6. PubMed ID: 2371579 [TBL] [Abstract][Full Text] [Related]
60. Changes in asthmatic patients' symptoms and lifestyles on institution of inhaled budesonide therapy. Nankani JN; Northfield M; Beran YM; Richardson PD Curr Med Res Opin; 1990; 12(3):198-206. PubMed ID: 2272194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]